Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Viking Therapeutics Inc (NASDAQ: VKTX) was $19.98 for the day, down -6.11% from the previous closing price of $21.28. In other words, the price has decreased by -$6.11 from its previous closing price. On the day, 6.01 million shares were traded. VKTX stock price reached its highest trading level at $22.74 during the session, while it also had its lowest trading level at $19.584.
Ratios:
Our analysis of VKTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 33.09 and its Current Ratio is at 33.09. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 08, 2025, initiated with a Neutral rating and assigned the stock a target price of $30.
On February 13, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $102.
On February 07, 2025, Citigroup started tracking the stock assigning a Neutral rating and target price of $38.Citigroup initiated its Neutral rating on February 07, 2025, with a $38 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 31 ’25 when Rouan Sarah Kathryn bought 1,240 shares for $24.15 per share. The transaction valued at 29,943 led to the insider holds 1,240 shares of the business.
Lian Brian sold 194,490 shares of VKTX for $8,313,601 on Jan 06 ’25. The President & CEO now owns 2,366,570 shares after completing the transaction at $42.75 per share. On Jan 06 ’25, another insider, Mancini Marianna, who serves as the Chief Operating Officer of the company, sold 54,215 shares for $42.75 each. As a result, the insider received 2,317,599 and left with 374,134 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 2242714880 and an Enterprise Value of 1637552384.
Stock Price History:
The Beta on a monthly basis for VKTX is 0.85, which has changed by -0.72114444 over the last 52 weeks, in comparison to a change of -0.034466684 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $81.86, while it has fallen to a 52-week low of $20.27. The 50-Day Moving Average of the stock is -30.78%, while the 200-Day Moving Average is calculated to be -58.98%.
Shares Statistics:
VKTX traded an average of 4.57M shares per day over the past three months and 4386290 shares per day over the past ten days. A total of 111.57M shares are outstanding, with a floating share count of 108.95M. Insiders hold about 2.94% of the company’s shares, while institutions hold 73.47% stake in the company. Shares short for VKTX as of 1741910400 were 24214313 with a Short Ratio of 5.30, compared to 1739491200 on 25107403. Therefore, it implies a Short% of Shares Outstanding of 24214313 and a Short% of Float of 28.9.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
